Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladislav Kovalik

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The American Surgeon|May 5, 2025
Presentation Patterns and Treatment Outcomes in Appendix Cancer Patients Traveling to a High-Volume Peritoneal Surface Malignancy CenterVladislav Kovalik, Armando Sardi, Mary Caitlin King, et al.
The American Surgeon|July 1, 2025
The Effect of Prior Nondefinitive Surgery on Perioperative Outcomes and Survival in Mucinous Appendix Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapySergei Iugai, Vadim Gushchin, Mary C King, et al.
Radiology Case Reports|November 9, 2019
CT-fusion-guided endovascular repair of iatrogenic common iliac artery aneurysm: A case reportAnton Khilchuk, Sergei Vlasenko, Musheg Muradyan, et al.
Clinical Pharmacology in Drug Development|December 20, 2024
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune ThrombocytopeniaAleksandr Petrov, Igor Makarenko, Bella Belova, et al.
World Journal of Surgical Oncology|August 26, 2025
Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgeryLuis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, et al.
Gynecologic Oncology Reports|June 17, 2026
The impact on sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer treatmentLuis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, et al.
Annals of Surgical Oncology|March 2, 2026
Patient-Reported Financial Toxicity of Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyVladislav Kovalik, Armando Sardi, Luis Felipe Falla-Zuniga, et al.
Gynecologic Oncology Reports|March 17, 2025
Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySergei Iugai, Armando Sardi, Teresa Diaz-Montes, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2025
Prognostic value of preoperative serum C-reactive protein level for survival in mucinous appendix cancer treated with complete CRS/HIPECAndrei Nikiforchin, Armando Sardi, Mary Caitlin King, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 25, 2026
Clinical characteristics and outcomes of patients with goblet cell adenocarcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC): A multicenter cohort studySergei Iugai, Vadim Gushchin, Mary Caitlin King, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The American Surgeon|May 5, 2025
Presentation Patterns and Treatment Outcomes in Appendix Cancer Patients Traveling to a High-Volume Peritoneal Surface Malignancy CenterVladislav Kovalik, Armando Sardi, Mary Caitlin King, et al.
The American Surgeon|July 1, 2025
The Effect of Prior Nondefinitive Surgery on Perioperative Outcomes and Survival in Mucinous Appendix Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapySergei Iugai, Vadim Gushchin, Mary C King, et al.
Radiology Case Reports|November 9, 2019
CT-fusion-guided endovascular repair of iatrogenic common iliac artery aneurysm: A case reportAnton Khilchuk, Sergei Vlasenko, Musheg Muradyan, et al.
Clinical Pharmacology in Drug Development|December 20, 2024
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune ThrombocytopeniaAleksandr Petrov, Igor Makarenko, Bella Belova, et al.
World Journal of Surgical Oncology|August 26, 2025
Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgeryLuis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, et al.
Gynecologic Oncology Reports|June 17, 2026
The impact on sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer treatmentLuis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, et al.
Annals of Surgical Oncology|March 2, 2026
Patient-Reported Financial Toxicity of Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyVladislav Kovalik, Armando Sardi, Luis Felipe Falla-Zuniga, et al.
Gynecologic Oncology Reports|March 17, 2025
Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySergei Iugai, Armando Sardi, Teresa Diaz-Montes, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2025
Prognostic value of preoperative serum C-reactive protein level for survival in mucinous appendix cancer treated with complete CRS/HIPECAndrei Nikiforchin, Armando Sardi, Mary Caitlin King, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 25, 2026
Clinical characteristics and outcomes of patients with goblet cell adenocarcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC): A multicenter cohort studySergei Iugai, Vadim Gushchin, Mary Caitlin King, et al.
Pageof 1